- Approval Id
- 794e8630fbd48303
- Drug Name
- CILOXAN STERILE OPHTHALMIC OINTMENT 3 mg/g
- Product Name
- CILOXAN STERILE OPHTHALMIC OINTMENT 3 mg/g
- Approval Number
- SIN11265P
- Approval Date
- 2000-01-28
- Registrant
- NOVARTIS (SINGAPORE) PTE LTD
- Licence Holder
- NOVARTIS (SINGAPORE) PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- OINTMENT
- Dosage
- **4 Dosage regimen and administration**
**Dosage Regimen**
Apply a 1/2” ointment ribbon into the conjunctival sac 3 times a day on the first 2 days, then apply a 1/2” ointment ribbon 2 times a day for the next 5 days.
**Special populations**
**Renal and hepatic Impairment**
No studies have been performed in patients with renal or hepatic impairment.
**Pediatric patients**
Safety and effectiveness of CILOXAN Eye Ointment in pediatric patients below the age of two years have not been established.
**Geriatric patients (65 years of age or above)**
No dosage regimen adjustments is required in patients 65 years of age or above.
**Method of administration**
**Ciloxan Eye ointment**
- For ocular use only
- After cap is removed, if tamper evident snap collar is loose, it should be removed before using the product.
- To avoid contamination, the tip of the tube should not touch any surface and should also not come into contact with the eye as this may cause injury to the eye. Keep the tube tightly closed when not in use.
- Either nasolacrimal occlusion or gently closing the eyelid(s) after administration is recommended. This may reduce the systemic absorption of medicinal products administered via the ocular route and result in a decrease in systemic adverse reactions.
- Patients should be advised not to wear contact lenses during treatment with CILOXAN eye ointment. Patients should remove contact lenses prior to application and wait at least 15 minutes before reinsertion.
- If more than one topical ophthalmic product is being used, the medicines must be administered at least 5 minutes apart. Eye ointments should be administered last.
- Route Of Administration
- OPHTHALMIC
- Indication Info
- **3 Indications**
**Ocular Use:**
- Ciloxan Eye Ointment is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin is a fluoroquinolone antibacterial.
Ciloxan Eye Ointment is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the microorganisms listed below:
**Gram-Positive:**
_Staphylococcus aureus_
_Staphylococcus epidermidis_
_Streptococcus pneumoniae_
_Streptococcus Viridans Group_
**Gram-Negative:**
_Haemophilus influenza_
- Contraindications
- **5 Contraindications**
Hypersensitivity to the active substance, or to other quinolones or to any of the excipients.
- Atc Code
- S01AX13
- Atc Item Name
- xs 01 ax 13
- Pharma Manufacturer Name
- NOVARTIS (SINGAPORE) PTE LTD
- Company Detail Path
- /organization/novartis-singapore-pte-ltd
